David Boulware
#125,577
Most Influential Person Now
Researcher
David Boulware's AcademicInfluence.com Rankings
David Boulwaremedical Degrees
Medical
#2575
World Rank
#3004
Historical Rank
Public Health
#428
World Rank
#442
Historical Rank
David Boulwarephilosophy Degrees
Philosophy
#8313
World Rank
#11666
Historical Rank
Logic
#5350
World Rank
#6741
Historical Rank
Download Badge
Medical Philosophy
Why Is David Boulware Influential?
(Suggest an Edit or Addition)According to Wikipedia, David Boulware is a professor of medicine and a practicing infectious disease physician at the University of Minnesota Medical School. He is a member of the graduate faculty for the University of Minnesota School of Public Health Epidemiology PhD program and for the Microbiology, Immunology, and Cancer Biology graduate program. Boulware was the first Lois & Richard King Distinguished Assistant Professorship at the University of Minnesota. Boulware is an active medical researcher engaged in clinical trials in infectious diseases.
David Boulware's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. (2017) (1313)
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 (2020) (1077)
- Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. (2014) (372)
- Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. (2011) (289)
- Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. (2008) (282)
- Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. (2010) (277)
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. (2010) (272)
- Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study (2010) (249)
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 (2020) (244)
- Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast (2014) (232)
- Travel medicine considerations for North American immigrants visiting friends and relatives. (2004) (230)
- Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study (2018) (226)
- Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. (2010) (175)
- Chitin Recognition via Chitotriosidase Promotes Pathologic Type-2 Helper T Cell Responses to Cryptococcal Infection (2015) (174)
- Cryptococcus: from human pathogen to model yeast (2011) (167)
- Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) (2020) (166)
- Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrast. (2012) (161)
- Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV Care (2012) (150)
- Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda (2015) (139)
- The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis (2014) (133)
- Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection (2010) (130)
- Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study (2016) (130)
- The Role of Nanoparticle Design in Determining Analytical Performance of Lateral Flow Immunoassays. (2017) (122)
- Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. (2005) (117)
- Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. (2007) (115)
- Cryptococcal Meningitis: Diagnosis and Management Update (2015) (113)
- Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19 (2021) (109)
- Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. (2014) (106)
- Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF. (2015) (105)
- The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis (2014) (104)
- Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda. (2016) (104)
- Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. (2009) (101)
- Cryptococcus neoformans Ex Vivo Capsule Size Is Associated With Intracranial Pressure and Host Immune Response in HIV-associated Cryptococcal Meningitis (2013) (94)
- Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings (2013) (92)
- GeneXpert MTB/Rif to Diagnose Tuberculous Meningitis: Perhaps the First Test but not the Last. (2016) (91)
- Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing (2018) (88)
- Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update (2013) (87)
- Cryptococcal Genotype Influences Immunologic Response and Human Clinical Outcome after Meningitis (2012) (85)
- Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis (2012) (84)
- Medical risks of wilderness hiking. (2003) (84)
- LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY (2015) (84)
- Methods of rapid diagnosis for the etiology of meningitis in adults. (2014) (83)
- Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection. (2007) (81)
- Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. (2008) (78)
- Central Nervous System Immune Reconstitution Inflammatory Syndrome (2013) (76)
- Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial (2020) (74)
- Effect of Early Treatment with Ivermectin among Patients with Covid-19 (2022) (73)
- Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis: a prospective validation study (2020) (73)
- Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study (2015) (72)
- Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality (2015) (71)
- Thermal Contrast Amplification Reader Yielding 8-Fold Analytical Improvement for Disease Detection with Lateral Flow Assays. (2016) (69)
- Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial (2020) (67)
- Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. (2019) (67)
- 1472Epidemiology of Meningitis in an HIV-infected Ugandan Cohort (2014) (62)
- Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical Implications (2011) (62)
- Lumbar puncture refusal in sub-Saharan Africa: A call for further understanding and intervention (2015) (61)
- Pediatric HIV immune reconstitution inflammatory syndrome (2008) (60)
- Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. (2022) (58)
- Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)–Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program (2017) (58)
- Comparative Genome Sequencing of an Isogenic Pair of USA800 Clinical Methicillin-Resistant Staphylococcus aureus Isolates Obtained before and after Daptomycin Treatment Failure (2011) (57)
- Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America (2013) (56)
- Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda (2012) (52)
- Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. (2019) (52)
- Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial (2015) (52)
- A randomized, controlled field trial for the prevention of jellyfish stings with a topical sting inhibitor. (2006) (52)
- Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness (2020) (51)
- Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia (2013) (48)
- Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. (2013) (47)
- Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study (2014) (47)
- Diagnosis and Management of Cryptococcal Relapse. (2013) (46)
- Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda (2017) (46)
- The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. (2022) (46)
- Systematic Review of Interventions for Depression for People Living with HIV in Africa (2017) (45)
- Cellular Immune Activation in Cerebrospinal Fluid From Ugandans With Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome (2014) (44)
- The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children (2010) (43)
- Cryptococcal meningitis: A neglected NTD? (2017) (42)
- Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation (2018) (42)
- Personal Protection Measures Against Mosquitoes, Ticks, and Other Arthropods. (2016) (42)
- Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis (2022) (42)
- Symptoms of COVID-19 Outpatients in the United States (2020) (40)
- A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis (2016) (39)
- Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis. (2016) (39)
- Etiology of Sepsis in Uganda Using a Quantitative Polymerase Chain Reaction-based TaqMan Array Card (2018) (39)
- Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis (2014) (37)
- HIV-Associated Cryptococcal Meningitis Occurring at Relatively Higher CD4 Counts (2018) (37)
- Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19 (2020) (37)
- The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum (2016) (37)
- Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis (2019) (36)
- Accuracy of Noninvasive Intraocular Pressure or Optic Nerve Sheath Diameter Measurements for Predicting Elevated Intracranial Pressure in Cryptococcal Meningitis (2014) (36)
- Fluvoxamine for Outpatient Management of COVID-19 to Prevent Hospitalization (2022) (34)
- AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (2018) (34)
- Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. (2016) (34)
- The Mouse Inhalation Model of Cryptococcus neoformans Infection Recapitulates Strain Virulence in Humans and Shows that Closely Related Strains Can Possess Differential Virulence (2019) (33)
- Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcL. (2012) (33)
- Backpacking-induced paresthesias. (2003) (33)
- AIDS-related mycoses: the way forward. (2014) (33)
- Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. (2011) (32)
- Influence of hygiene on gastrointestinal illness among wilderness backpackers. (2004) (32)
- Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV‐infected patients in São Paulo, Brazil (2016) (31)
- Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial (2018) (31)
- Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections (2016) (31)
- Standardized Electrolyte Supplementation and Fluid Management Improves Survival During Amphotericin Therapy for Cryptococcal Meningitis in Resource-Limited Settings (2014) (31)
- Burden of Depression in Outpatient HIV-Infected adults in Sub-Saharan Africa; Systematic Review and Meta-analysis (2019) (30)
- A Systematic Review of Treatment and Outcomes of Pregnant Women With COVID-19—A Call for Clinical Trials (2020) (30)
- Xpert MTB/RIF Ultra for Tuberculosis Testing in Children: A Mini-Review and Commentary (2019) (30)
- Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update (2019) (30)
- The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017 (2019) (30)
- Physician Preferences for Elements of Effective Consultations (2009) (30)
- Antimicrobial Drug Resistance in Blood Culture Isolates at a Tertiary Hospital, Uganda (2018) (30)
- Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis. (2018) (29)
- Leptospira Seroprevalence and Risk Factors in Health Centre Patients in Hoima District, Western Uganda (2016) (29)
- Methods for rapid diagnosis of meningitis etiology in adults (2020) (29)
- Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection (2019) (28)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (27)
- Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs. (2016) (27)
- Inadequate diagnostics: the case to move beyond the bacilli for detection of meningitis due to Mycobacterium tuberculosis. (2019) (26)
- A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in Uganda (2018) (26)
- Acute Heart Failure From Lyme Carditis (2012) (25)
- Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100 (2014) (25)
- Gender differences among long-distance backpackers: A prospective study of women Appalachian Trail backpackers. (2004) (24)
- Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. (2012) (24)
- Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults (2019) (23)
- Antiretroviral Therapy Down-Regulates Innate Antiviral Response Genes in Patients With AIDS in Sub-Saharan Africa (2010) (23)
- Impact of global health residency training on medical knowledge of immigrant health. (2011) (23)
- High-Dose Oral and Intravenous Rifampicin for the Treatment of Tuberculous Meningitis in Predominantly Human Immunodeficiency Virus (HIV)-Positive Ugandan Adults: A Phase II Open-Label Randomized Controlled Trial (2021) (23)
- Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy (2017) (23)
- Recent Increases in the U.S. Maternal Mortality Rate: Disentangling Trends From Measurement Issues. (2017) (22)
- Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis (2017) (22)
- Detection of Mycobacterium tuberculosis in urine by Xpert MTB/RIF Ultra: A useful adjunctive diagnostic tool in HIV-associated tuberculosis (2018) (21)
- Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal Antigenemia (2020) (21)
- Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward (2020) (21)
- Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis (2017) (21)
- Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward (2020) (21)
- Treatment Outcomes in Adult Tuberculous Meningitis: A Systematic Review and Meta-analysis (2020) (21)
- Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B (2020) (21)
- The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy (2017) (21)
- Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis (2013) (20)
- Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence (2021) (20)
- Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection (2018) (20)
- Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection (2012) (19)
- Diagnostic Delay and Antibiotic Overuse in Acute Pulmonary Blastomycosis (2016) (19)
- Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. (2007) (19)
- Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected Meningitis (2020) (18)
- Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center (2018) (18)
- Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda (2019) (18)
- Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis (2015) (18)
- Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding (2015) (18)
- Cryptococcal Meningitis and Tuberculous Meningitis Co-infection in HIV-Infected Ugandan Adults (2018) (18)
- High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study) (2018) (17)
- Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19 (2020) (17)
- Hookworm infection is associated with decreased CD4+ T cell counts in HIV-infected adult Ugandans (2017) (17)
- Seroprevalence of histoplasmosis in Kampala, Uganda. (2016) (17)
- Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts (2017) (17)
- Point-of-Care Lung Ultrasound for COVID-19: Findings and Prognostic Implications From 105 Consecutive Patients (2021) (16)
- Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome (2017) (16)
- A Systematic Review of Non-Traumatic Spinal Cord Injuries in Sub-Saharan Africa and a Proposed Diagnostic Algorithm for Resource-Limited Settings (2017) (16)
- Passive Prophylaxis With Permethrin-Treated Tents Reduces Mosquito Bites Among North American Summer Campers (2005) (16)
- Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model (2019) (16)
- Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings (2017) (16)
- Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics (2022) (16)
- Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution (2015) (16)
- Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality (2018) (15)
- Accuracy of Xpert Ultra in Diagnosis of Pulmonary Tuberculosis among Children in Uganda: a Substudy from the SHINE Trial (2020) (15)
- Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial (2020) (15)
- Laboratory-Reflex Cryptococcal Antigen Screening Is Associated With a Survival Benefit in Tanzania (2019) (15)
- A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis (2015) (15)
- Absence of cerebrospinal fluid pleocytosis in tuberculous meningitis is a common occurrence in HIV co-infection and a predictor of poor outcomes. (2018) (15)
- Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa. (2019) (14)
- Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in Uganda. (2018) (14)
- Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitis. (2018) (14)
- Tuberculous meningitis diagnosis and outcomes during the Xpert MTB/Rif era: a 6.5-year cohort study in Uganda (2018) (13)
- Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation (2014) (13)
- Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa (2014) (13)
- Fujifilm SILVAMP TB LAM assay on cerebrospinal fluid for the detection of tuberculous meningitis in HIV-infected adults. (2021) (13)
- Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review (2020) (13)
- Detection of Cryptococcus DNA by Metagenomic Next-generation Sequencing in Symptomatic Cryptococcal Antigenemia. (2018) (12)
- Hypereosinophilic syndrome and mepolizumab. (2008) (12)
- Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. (2022) (12)
- CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients. (2017) (12)
- Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes (2019) (11)
- Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus (2014) (11)
- OUTCOMES OF CRYPTOCOCCAL MENINGITIS IN UGANDA BEFORE AND AFTER THE AVAILABILITY OF HAART (2008) (11)
- Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2 (2020) (11)
- Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016 (2017) (11)
- Prevalence of Medical Contraindications to Nirmatrelvir/Ritonavir in a Cohort of Hospitalized and Nonhospitalized Patients With COVID-19 (2022) (10)
- Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients. (2019) (10)
- Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients (2017) (10)
- Short‐course amphotericin B in addition to sertraline and fluconazole for treatment of HIV‐associated cryptococcal meningitis in rural Tanzania (2019) (10)
- Adjunctive sertraline for asymptomatic cryptococcal antigenemia: A randomized clinical trial. (2020) (10)
- HIV-Associated Cryptococcal Immune Reconstitution Inflammatory Syndrome Is Associated with Aberrant T Cell Function and Increased Cytokine Responses (2019) (10)
- The conundrum of clinical trials and standard of care in sub-Saharan Africa – the research nurse perspective (2019) (10)
- Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19 (2022) (10)
- Ending deaths from HIV-related cryptococcal meningitis by 2030. (2020) (10)
- Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population. (2021) (9)
- Epidemiology of non-traumatic spinal cord injury in Uganda: a single center, prospective study with MRI evaluation (2019) (9)
- Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure (2019) (9)
- 1,3-β-D-glucan in cryptococcal meningitis. (2015) (9)
- Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis (2017) (9)
- Hydroxychloroquine for COVID19: The curtains close on a comedy of errors (2022) (9)
- Cryptococcal Disease in the Era of “Test and Treat”: Is There Cause for Concern? (2017) (9)
- Fluvoxamine for the treatment of COVID-19 (2022) (8)
- Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons A Before–After Study in Uganda (2016) (8)
- Cerebrospinal Fluid Bacillary Load by Xpert MTB/RIF Ultra Polymerase Chain Reaction Cycle Threshold Value Predicts 2-Week Mortality in Human Immunodeficiency Virus–Associated Tuberculous Meningitis (2020) (8)
- Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study (2019) (8)
- HIV care: ART adherence support and cryptococcal screening (2015) (8)
- High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study). (2019) (8)
- Cryptococcal antigen screening and preemptive treatment - how can we improve survival? (2019) (8)
- Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis (2021) (7)
- Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial (2022) (7)
- AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study (2019) (7)
- Host Directed Therapies for Tuberculous Meningitis. (2020) (7)
- Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis (2020) (7)
- Unmasking Cryptococcal Meningitis Immune Reconstitution Inflammatory Syndrome due to Granulocyte Colony-Stimulating Factor Use in a Patient with a Poorly Differentiated Germ Cell Neoplasm (2014) (7)
- Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative CSF analysis (2019) (7)
- Gastrointestinal cryptococcoma – Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS? (2015) (7)
- Establishing targets for advanced HIV disease: A call to action (2021) (7)
- Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. (2023) (7)
- A case for treating high hepatitis B DNA levels before starting HIV therapy. (2006) (7)
- Cryptococcal Antigenemia in HIV therapy-experienced Ugandans with Virologic Failure. (2019) (7)
- Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection (2020) (6)
- Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART (2016) (6)
- Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid (2018) (6)
- Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms (2022) (6)
- Xpert MTB/RIF® assay for the diagnosis of HIV-related tuberculous meningitis in São Paulo, Brazil. (2018) (6)
- Is it possible to differentiate tuberculous and cryptococcal meningitis in HIV-infected patients using only clinical and basic cerebrospinal fluid characteristics? (2017) (6)
- Illuminating Tuberculosis Meningitis with Metagenomics and FLASH Enrichment (S45.005) (2019) (6)
- Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis. (2020) (6)
- Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease (2022) (6)
- Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda. (2013) (6)
- Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management. (2019) (6)
- Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases (2022) (6)
- Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death (2020) (6)
- Performance of Lipoarabinomannan Assay using Cerebrospinal fluid for the diagnosis of Tuberculous meningitis among HIV patients (2019) (6)
- Improved Influenza Diagnostics through Thermal Contrast Amplification (2021) (6)
- A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda (2018) (6)
- Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up (2022) (5)
- The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis (2021) (5)
- Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis (2018) (5)
- Travel medicine for the extreme traveler. (2005) (5)
- Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis (2015) (5)
- CSF early fungicidal activity as a surrogate endpoint for cryptococcal meningitis survival in clinical trials. (2020) (5)
- A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration. (2020) (5)
- Performance of nested RT-PCR on CSF for tuberculous meningitis diagnosis in HIV-infected patients. (2017) (5)
- Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial (2022) (5)
- Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials (2020) (4)
- Safety, censoring, and intent-to-treat analysis: dangers to generalizability. (2010) (4)
- Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis (2019) (4)
- Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies. (2019) (4)
- Ophthalmic signs in Ugandan adults with HIV-associated cryptococcal meningitis: A nested analysis of the ASTRO-CM cohort. (2018) (4)
- Xpert MTB/Rif Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis: A Prospective Validation (2019) (4)
- Tuberculosis Immune Reconstitution Syndrome Among Ugandan Children (2008) (4)
- Etiology of Sepsis in Uganda using a Quantitative PCR-based TaqMan Array Card. (2019) (4)
- Diagnostic accuracy of Xpert MTB/RIF for tuberculous meningitis: systematic review and meta‐analysis (2020) (4)
- Seroprevalence of Histoplasmosis in Somali, Burmese, and Hmong Refugees Residing in Thailand and Kenya (2018) (4)
- Cryptococcal meningitis is a cause for cross‐reactivity in cerebrospinal fluid assays for anti‐Histoplasma, anti‐Coccidioides and anti‐Blastomyces antibodies (2019) (4)
- New FDA approvals decrease generic flucytosine costs. (2019) (3)
- Tuberculosis at the animal–human interface in the Ugandan cattle corridor using a third-generation sequencing platform: a cross-sectional analysis study (2019) (3)
- Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trial. (2022) (3)
- Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis (2020) (3)
- Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic (2020) (3)
- Poor specificity of urinary cryptococcal antigen testing (2018) (3)
- New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs (2019) (3)
- Fluvoxamine for Outpatient COVID-19 to Prevent Hospitalization: A Systematic Review and Meta-Analysis (2021) (3)
- Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis (2017) (3)
- Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis (2020) (3)
- CHAPTER 18 – HIV Immune Reconstitution Inflammatory Syndrome (2008) (3)
- Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitis (2019) (3)
- 1791Evaluating Cryptococcal Antigen Lateral Flow Assay by Fingerstick Whole Blood in HIV-Infected Persons with Meningitis (2014) (3)
- Improved detection of group A Streptococcus during thermal contrast amplification vs. visual reading of clinical rapid diagnostic tests (2019) (3)
- 1468Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis (2014) (3)
- B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal Meningitis (2019) (3)
- Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 (2021) (3)
- Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort (2022) (3)
- Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda (2020) (3)
- Cerebrospinal fluid AFB smear in adults with tuberculous meningitis: A systematic review and diagnostic test accuracy meta-analysis. (2022) (3)
- Outpatient Cryptococcal Antigen Screening is Associated with Favorable Baseline Characteristics and Improved Survival in Persons with Cryptococcal Meningitis in Uganda. (2022) (3)
- Pneumococcal Pneumonia in Adults: Epidemiology, Clinical Features, Diagnosis, and Therapy (2008) (3)
- Low rates of Hepatitis B and Human Immunodeficiency Virus coinfection in rural northern Tanzania (2015) (2)
- Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin? (2018) (2)
- Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal Meningitis (2016) (2)
- Sertraline for HIV-associated cryptococcal meningitis - Authors' reply. (2016) (2)
- Host Directed Therapies for Tuberculous Meningitis (2020) (2)
- Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial (2019) (2)
- The trials of the returning traveler: ciprofloxacin failure in enteric fever. (2008) (2)
- Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality (2022) (2)
- Severe Babesiosis in Immunocompetent Man, Spain, 2011 (2018) (2)
- Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management? (2022) (2)
- Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. (2023) (2)
- Early Treatment with Fluvoxamine among Patients with COVID-19: A Cost-Consequence Model (2021) (2)
- Sex-specific associations between cerebrospinal fluid inflammatory marker levels and cognitive function in antiretroviral treated people living with HIV in rural Uganda (2020) (2)
- 1432Diagnostic Performance of a Multiplex PCR Assay for Meningitis in an HIV-Infected Population in Uganda (2014) (2)
- High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study) (2019) (2)
- Towards a scalable HIV cure research agenda: the role of co-infections (2015) (2)
- ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC50 (2021) (2)
- Ongoing Need for Clinical Trials and Contemporary End Points for Outpatient COVID-19 (2022) (2)
- Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis (2019) (2)
- Neurocognitive outcomes of HIV-associated tuberculous meningitis. (2021) (2)
- CSFLAM_data set revised (2019) (1)
- Case Report: Three's a crowd: a case report examining the diagnostic and pharmacokinetic challenges in HIV-tuberculous meningitis-malaria co-infection. (2018) (1)
- Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: Study Protocol for a Pragmatic Randomized Controlled Trial (2020) (1)
- Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis (2022) (1)
- Cerebrospinal fluid bacillary load by Xpert MTB/RIF Ultra PCR Cycle Threshold value predicts two-week mortality in HIV-associated tuberculous meningitis (2020) (1)
- LB1528B. Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial (2022) (1)
- Rapid Diagnosis of Streptococcus pneumoniae Infection among HIV-infected Adults by Urine Antigen Detection and CRP (2005) (1)
- Routine Cryptococcal Antigen Screening in Solid Organ Transplant Recipients: Is it Time to Save Lives and Money? (2017) (1)
- Technical procedures and REDCap tools for internet-based clinical trials (2022) (1)
- Antimicrobial Resistance in Uganda and the Urgent Need for Standardized Reporting and a National Surveillance Program (2015) (1)
- Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting (2020) (1)
- Survival in HIV-infected Asymptomatic Cryptococcal Antigenemia without CSF Positivity Treated with Fluconazole Did Not Differ from Cryptococcal Antigen (CrAg) Negative with CD4 <150. (2017) (1)
- Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda. (2020) (1)
- Fatty Liver in Hispanics with HIV. (2016) (1)
- Reply to author. (2020) (1)
- Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial (2022) (1)
- Immune Reconstitution Inflammatory Syndrome in HIV Infected Ugandans (2007) (1)
- HIV-Associated Cryptococcal Meningitis Patients Treated with Amphotericin B Deoxycholate Plus Flucytosine under Routine Care Conditions in a Referral Center in São Paulo, Brazil (2020) (1)
- Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies. (2022) (1)
- Hearing Loss in Cryptococcal Meningitis Survivors (2017) (1)
- Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies (2019) (1)
- Change in plasma CrAg titer is not associated with survival among HIV-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia. (2020) (1)
- Clinical mycology today: A synopsis of the mycoses study group education and research consortium (MSGERC) second biennial meeting, September 27-30, 2018, Big Sky, Montana, a proposed global research agenda. (2020) (1)
- Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda (2021) (1)
- Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis (2019) (1)
- Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda (2016) (1)
- High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin. (2021) (1)
- CHAPTER 40 – Strongyloides (2007) (1)
- A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis. (2021) (1)
- Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting (2020) (1)
- Xpert Ultra's place in the diagnosis of tuberculous meningitis - Authors' reply. (2018) (1)
- Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial (2022) (1)
- Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort (2022) (1)
- Distance From Cervicovaginal Junction to Anterior Peritoneal Reflection Measured During Vaginal Hysterectomy (2017) (1)
- Fujifilm SILVAMP TB LAM Assay on Cerebrospinal Fluid for the Detection of Tuberculous Meningitis in Adults With Human Immunodeficiency Virus (2021) (1)
- Cost-effectiveness of single-dose AmBisome preemptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries. (2022) (1)
- Reply to Neves (2020) (0)
- Case Report: Three's a crowd: a case report examining the diagnostic and pharmacokinetic challenges in HIV-tuberculous meningitis-malaria co-infection (2018) (0)
- Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study (2014) (0)
- A post-mortem analysis of tenofovir, lamivudine, efavirenz and fluconazole penetration in female genital tissues. (2022) (0)
- Natural History of the Variation in HIV-1 Viral Load in persons with CD4 + T-cell >200 cells/µL in the Anti-Retroviral Era: Implications for Study Design and Sample Size Determination (2006) (0)
- How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings? (2022) (0)
- Insect Bite Prevention (2015) (0)
- Neurocognitive outcomes of HIV-associated tuberculous meningitis [version 1; peer review: awaiting peer review] (2021) (0)
- Evaluation of the effectiveness of a South African laboratory cryptococcal antigen screening programme using a retrospective cohort and a cluster-randomised trial design (2022) (0)
- Response and Human Clinical Outcome after Meningitis Cryptococcal Genotype Influences Immunologic 2012 (2012) (0)
- Closely related Cryptococcus neoformans strains possess differential virulence both in humans and the mouse inhalation model (2019) (0)
- Migrants, detainees, and misconceptions (2009) (0)
- Images and Case Reports in Heart Failure Acute Heart Failure From Lyme Carditis (2012) (0)
- Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis (2021) (0)
- Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristics. (2022) (0)
- Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis (2022) (0)
- LB2303. Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial (2022) (0)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (0)
- Neurocognitive outcomes of HIV-associated tuberculous meningitis [version 1; peer review: 1 approved with reservations] (2021) (0)
- Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda. (2022) (0)
- Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based (2019) (0)
- Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda. (2022) (0)
- Host Directed Therapies for Tuberculous Meningitis [version 2; peer review: 1 approved, 1 approved with reservations] (2021) (0)
- 2361. Timing of antiretroviral therapy prior to diagnosis of cryptococcal meningitis (2022) (0)
- Ophthalmic signs in Ugandan adults with HIV-associated cryptococcal meningitis: A nested analysis of the ASTRO-CM cohort (2018) (0)
- Case 8-2017. A 39-Year-Old Zimbabwean Man with a Severe Headache. (2017) (0)
- Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial 1 (2020) (0)
- The Worldwide Burden and Challenge of Cryptococcal Infection (2017) (0)
- Host Directed Therapies for Tuberculous Meningitis [version 1; peer review: awaiting peer review] (2021) (0)
- Use of Microarrays to Assess Immune Activation in HIV Immune Reconstitution Inflammatory Syndrome (2007) (0)
- Reproducibility of CSF quantitative culture methods for Cryptococcus neoformans (2014) (0)
- 1703Delta-like 1 ligand (DLL) measurement in cerebrospinal fluid for detection of Mycobacterium tuberculosis meningitis (2014) (0)
- Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic? (2022) (0)
- Should we perform the serum cryptococcal antigen test in people living with HIV hospitalized due to a community-acquired pneumonia episode? (2020) (0)
- Track B Clinical Science (2012) (0)
- Impact of MYH6 Variants on Development and Clinical Course of Hypoplastic Left Heart Syndrome (2021) (0)
- Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic Review (2022) (0)
- 88462 Fluconazole distribution in CNS and gynecological tissues in HIV-related cryptococcal meningitis decedents (2021) (0)
- 68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment. (2023) (0)
- Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply. (2022) (0)
- Timing of antiretroviral therapy in cryptococcal meningitis: What we can (and cannot) learn from observational data. (2023) (0)
- Methods : An open-label phase III randomised controlled non-inferiority trial conducted in five countries in sub-Saharan Africa (2019) (0)
- Adherence of health workers to guidelines for screening and management of cryptococcal meningitis in Uganda (2023) (0)
- Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials (2023) (0)
- A secondary analysis of depression outcomes from a randomized controlled trial of adjunctive sertraline for HIV-associated cryptococcal meningitis (2022) (0)
- 2120. Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction Model (2019) (0)
- 038 Resolving infectious meningitis in uganda with metagenomics and host transcriptomics (2021) (0)
- P-A12 Discordant HIV populations with discordant V3 tropism in CSF and Plasma: Implications for establishing HIV reservoirs (2018) (0)
- High Dose Fluconazole Monotherapy is Inadequate for Cerebrospinal Fluid Cryptococcal Antigen Positive (CRAG+) Persons in a CRAG Screening Program in Ethiopia (2015) (0)
- Development of Anemia and Changes in Hemoglobin Concentrations with Amphotericin B Therapy for Cryptococcal Meningitis (2015) (0)
- Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis (2017) (0)
- Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa. (2021) (0)
- Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia (2023) (0)
- Rates of refusal of clinical autopsies among HIV-positive decedents and an overview of autopsies in Uganda (2021) (0)
- Erratum to: The Changing Epidemiology of HIV-Associated Adult Meningitis, Uganda 2015–2017 (2019) (0)
- Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda (2019) (0)
- Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 (2023) (0)
- “There are many fevers”: Communities’ perception and management of Febrile illness and its relationship with human animal interactions in South-Western Uganda (2022) (0)
- Fever, rash, and pain in the extremities of returning pediatric travelers (2015) (0)
- Case 8-2017: A Zimbabwean Man with a Severe Headache. (2017) (0)
- Effi cacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis : an open-label dose-ranging study (2016) (0)
- Host Directed Therapies for Tuberculous Meningitis [version 1; peer review: 1 approved with reservations] (2021) (0)
- Can COVID-19 changes reduce stigma in African HIV clinics? (2022) (0)
- Management of advanced HIV disease in Africa. (2023) (0)
- Mulalama (Taking Water) (2015) (0)
- P5.074 Immune Activation After Stimulation with Cryptococcus Neoformans Antigens Pre and Post ART Initiation in HIV-1 Positive Ugandans (2013) (0)
- 1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis (2019) (0)
- Enhanced Consolidation Therapy With High-Dose Fluconazole and Sertraline Ameliorates Negative Outcomes Associated With Persistent Cerebrospinal Fluid Culture Positivity in Cryptococcal Meningitis (2015) (0)
- Differences in Reasons for Late Presentation to HIV Care in Uganda Among Men and Women (2022) (0)
- Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials (2021) (0)
- Monocyte deactivation is associated with mortality in HIV-associated cryptococcal meningitis (2015) (0)
- The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials. (2023) (0)
- Passive Prophylaxis with Permethrin Treated Tents Reduces Mosquito Bites among North American Campers (2004) (0)
- Antiretroviral therapy after cryptococcal meningitis. (2014) (0)
- Illuminating meningococcal diagnosis with LAMP. (2015) (0)
- 869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial (2022) (0)
- CHAPTER 17 – Diseases with Long Latency Periods (2007) (0)
- Differences in immunologic factors among those presenting with altered mental status in cryptococcal meningitis (2015) (0)
This paper list is powered by the following services:
Other Resources About David Boulware
What Schools Are Affiliated With David Boulware?
David Boulware is affiliated with the following schools:
